摘要
目的:分析儿科住院患者吸入用布地奈德混悬液的使用情况,为临床合理用药提供参考。方法:采用回顾性调查方法,从2018年5月至2019年4月儿科住院患者吸入用布地奈德混悬液使用率前10位科室中,每个科室随机抽取30份病历,共计300份,对吸入用布地奈德混悬液的使用情况进行统计和分析。结果:107例(35.6%)适应证不合理,148例(49.3%)用药频次不合理,231例(77.0%)雾化时合并使用了其他药物,4例发生不良反应。结论:医院应加强超说明书用药的监管,制定吸入用布地奈德混悬液合理用药标准,提高合理用药水平。
Objective:To analyze the application of inhalation of budesonide suspension in pediatric inpatients,so as to provide reference for rational drug use in clinic.Methods:Retrospective analysis was adopted,30 medical records in every top 10 departments with inhalation of budesonide suspension for inpatients from May 2018 to Apr.2019 were statistically collected and analyzed.Results:There were 107 cases(35.6%)with irrational indications,148 cases(49.3%)with irrational medication frequency,231 cases(77.0%)with drug combination of other drugs during inhalation,and 4 cases with adverse drug reactions.Conclusion:Hospitals should strengthen the supervision of off-label drug use,formulate standards for the rational use of inhalation of budesonide and improve the level of rational drug use.
作者
陶婉君
江永贤
李莉
蔡江晖
陈文文
李根
Tao Wanjun;Jiang Yongxian;Li Li;Cai Jianghui;Chen Wenwen;Li Gen(Chengdu Women's and Children's Central Hospital School of Medicine,University of Electronic Science and Technologly of China,Sichuan Chengdu 611731,China)
出处
《儿科药学杂志》
CAS
2021年第5期43-46,共4页
Journal of Pediatric Pharmacy
关键词
吸入用布地奈德混悬液
超说明书用药
儿童
处方分析
不良反应
inhalation of budesonide suspension
off-label drug use
children
prescription analysis
adverse drug reactions
